Skip to Content

Rheumocam Injection 20 mg/mL (Canada)

This page contains information on Rheumocam Injection 20 mg/mL for veterinary use.
The information provided typically includes the following:
  • Rheumocam Injection 20 mg/mL Indications
  • Warnings and cautions for Rheumocam Injection 20 mg/mL
  • Direction and dosage information for Rheumocam Injection 20 mg/mL

Rheumocam Injection 20 mg/mL

This treatment applies to the following species:
Manufacturer: Merck Animal Health

Meloxicam 20 mg/mL

Veterinary Use Only

DIN 02452146


A clear yellow solution containing 20 mg of meloxicam per mL. Ethanol (dehydrated) Ph. Eur. 150 mg/mL is the preservative.

Therapeutic Classification: Rheumocam Injection is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam group.

Rheumocam Injection 20 mg/mL Indications

As an aid in improving appetite and weight gains when administered at the onset of diarrhoea, in combination with oral rehydration therapy, in calves over one week of age.

For relief of pain following de-budding of horn buds in calves less than 3 months of age.

Dosage and Administration

single subcutaneous or intravenous injection of 0.5 mg meloxicam/kg body weight (i.e. 2.5 mL/100 kg body weight).


Do not use in breeding, lactating or pregnant animals. Do not use in bulls intended for breeding.

Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders or where there is individual hypersensitivity to the product.

Do not administer concurrently with steroidal or other non- steroidal anti-inflammatory drugs (NSAIDs) or with anti-coagulant agents.

Concomitant use of NSAIDs with aminoglycoside antimicrobials in very young animals may result in renal toxicity.

Cautions: Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which require parenteral rehydration, as there may be a potential risk of increased renal toxicity.

Use of anti-inflammatories in very young or debilitated animals may involve additional risk.

Transient, slight injection site swellings may occasionally be seen following subcutaneous injection and intravenous injection. Safety and efficacy of Rheumocam Injection has not been established in other species.


Treated animals should not be slaughtered for use in food for at least 20 days after the latest treatment with this drug. Do not use in dairy cows 20 months of age or older. Do not use in calves to be processed for veal as a withdrawal period has not been established for pre-ruminant calves. Keep out of the reach of children.

Adverse Reactions

In very rare cases, anaphylactoid reactions may occur and should be treated symptomatically.

Clinical Pharmacology

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class which acts by inhibition of prostaglandin synthesis, thereby exerting anti-inflammatory, analgesic and antipyretic effects. Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by E. coli endotoxin administration in calves.

Toxicology: The acute oral toxicity (LD50) of meloxicam assessed in rats, mini-pigs, mice and rabbits was >80 mg/kg, 1600 mg/kg, 470 mg/kg and 320 mg/kg, respectively. Repeated dose toxicity studies in rats, mice and mini-pigs demonstrated that the primary target organs for toxicity were the gastrointestinal tract (pyloric, duodenal and small intestinal ulceration) and kidneys (scarring, necrosis and pyelonephritis).


Store between 15° to 25°C. Keep from freezing.

Discard after 28 days from first opening.

Presentation: 50 mL, 100 mL, 250 mL bottles

Manufactured by:

Chanelle Pharmaceuticals Manufacturing Ltd., Loughrea, Co. Galway, Ireland

Distributed by:

Intervet Canada Corp. subsidiary of Merck & Co., Inc., 16750, route Transcanadienne, Kirkland, QC H9H 4M7

1 866-683-7838



CPN: 1208284.0

Intervet Canada Corp.

Order Desk:   514-428-7013
Toll-Free:   866-683-7838
Fax:   Toll-free 888-498-4444; local 514-428-7014
Every effort has been made to ensure the accuracy of the Rheumocam Injection 20 mg/mL information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2018 North American Compendiums. Updated: 2018-02-26